Annual EBITDA
-$22.72 M
+$8.11 M+26.31%
December 31, 2023
Summary
- As of March 10, 2025, INKT annual EBITDA is -$22.72 million, with the most recent change of +$8.11 million (+26.31%) on December 31, 2023.
- During the last 3 years, INKT annual EBITDA has fallen by -$8.97 million (-65.30%).
- INKT annual EBITDA is now -65.30% below its all-time high of -$13.74 million, reached on December 31, 2020.
Performance
INKT EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$1.82 M
+$1.20 M+39.79%
September 30, 2024
Summary
- As of March 10, 2025, INKT quarterly EBITDA is -$1.82 million, with the most recent change of +$1.20 million (+39.79%) on September 30, 2024.
- Over the past year, INKT quarterly EBITDA has stayed the same.
- INKT quarterly EBITDA is now -118.96% below its all-time high of -$832.10 thousand, reached on December 31, 2020.
Performance
INKT Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$14.07 M
+$3.35 M+19.22%
September 30, 2024
Summary
- As of March 10, 2025, INKT TTM EBITDA is -$14.07 million, with the most recent change of +$3.35 million (+19.22%) on September 30, 2024.
- Over the past year, INKT TTM EBITDA has stayed the same.
- INKT TTM EBITDA is now -161.08% below its all-time high of -$5.39 million, reached on September 30, 2020.
Performance
INKT TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
INKT EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +26.3% | 0.0% | 0.0% |
| 3 y3 years | -65.3% | 0.0% | 0.0% |
| 5 y5 years | -2.3% | 0.0% | 0.0% |
INKT EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +26.3% | at high | +77.1% | at high | +59.5% |
| 5 y | 5-year | -65.3% | +26.3% | -119.0% | +86.4% | -161.1% | +59.5% |
| alltime | all time | -65.3% | +26.3% | -119.0% | +86.4% | -161.1% | +59.5% |
MiNK Therapeutics EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$1.82 M(-39.8%) | -$14.07 M(-19.2%) |
| Jun 2024 | - | -$3.03 M(-19.9%) | -$17.42 M(-15.8%) |
| Mar 2024 | - | -$3.78 M(-30.7%) | -$20.68 M(-8.9%) |
| Dec 2023 | -$22.72 M(-26.3%) | -$5.45 M(+5.3%) | -$22.72 M(-9.6%) |
| Sep 2023 | - | -$5.17 M(-17.8%) | -$25.12 M(-10.0%) |
| Jun 2023 | - | -$6.29 M(+8.3%) | -$27.91 M(-4.7%) |
| Mar 2023 | - | -$5.81 M(-26.0%) | -$29.29 M(-5.0%) |
| Dec 2022 | -$30.83 M | -$7.85 M(-1.4%) | -$30.83 M(+5.2%) |
| Sep 2022 | - | -$7.96 M(+3.8%) | -$29.31 M(-15.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$7.67 M(+4.4%) | -$34.71 M(+6.4%) |
| Mar 2022 | - | -$7.35 M(+15.9%) | -$32.64 M(+15.0%) |
| Dec 2021 | -$28.28 M(+105.8%) | -$6.34 M(-52.5%) | -$28.37 M(+24.1%) |
| Sep 2021 | - | -$13.36 M(+138.7%) | -$22.87 M(+53.5%) |
| Jun 2021 | - | -$5.59 M(+81.3%) | -$14.90 M(+60.1%) |
| Mar 2021 | - | -$3.09 M(+270.9%) | -$9.31 M(+49.6%) |
| Dec 2020 | -$13.74 M(-38.1%) | -$832.10 K(-84.6%) | -$6.22 M(+15.4%) |
| Sep 2020 | - | -$5.39 M | -$5.39 M |
| Dec 2019 | -$22.20 M | - | - |
FAQ
- What is MiNK Therapeutics annual EBITDA?
- What is the all time high annual EBITDA for MiNK Therapeutics?
- What is MiNK Therapeutics annual EBITDA year-on-year change?
- What is MiNK Therapeutics quarterly EBITDA?
- What is the all time high quarterly EBITDA for MiNK Therapeutics?
- What is MiNK Therapeutics quarterly EBITDA year-on-year change?
- What is MiNK Therapeutics TTM EBITDA?
- What is the all time high TTM EBITDA for MiNK Therapeutics?
- What is MiNK Therapeutics TTM EBITDA year-on-year change?
What is MiNK Therapeutics annual EBITDA?
The current annual EBITDA of INKT is -$22.72 M
What is the all time high annual EBITDA for MiNK Therapeutics?
MiNK Therapeutics all-time high annual EBITDA is -$13.74 M
What is MiNK Therapeutics annual EBITDA year-on-year change?
Over the past year, INKT annual EBITDA has changed by +$8.11 M (+26.31%)
What is MiNK Therapeutics quarterly EBITDA?
The current quarterly EBITDA of INKT is -$1.82 M
What is the all time high quarterly EBITDA for MiNK Therapeutics?
MiNK Therapeutics all-time high quarterly EBITDA is -$832.10 K
What is MiNK Therapeutics quarterly EBITDA year-on-year change?
Over the past year, INKT quarterly EBITDA has changed by $0.00 (0.00%)
What is MiNK Therapeutics TTM EBITDA?
The current TTM EBITDA of INKT is -$14.07 M
What is the all time high TTM EBITDA for MiNK Therapeutics?
MiNK Therapeutics all-time high TTM EBITDA is -$5.39 M
What is MiNK Therapeutics TTM EBITDA year-on-year change?
Over the past year, INKT TTM EBITDA has changed by $0.00 (0.00%)